Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Clinical trial NCT01473056 · COMPLETED

Trial details

NCT number: NCT01473056
Sponsor: Akros Pharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis C Virus Infection, Response to Therapy of

Start date: 2010-08-01
Primary completion: 2010-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.